<VariationArchive VariationID="2008330" VariationName="NM_001453.3(FOXC1):c.474dup (p.Tyr159fs)" VariationType="Duplication" Accession="VCV002008330" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2066280" VariationID="2008330">
      <GeneList>
        <Gene Symbol="FOXC1" FullName="forkhead box C1" GeneID="2296" HGNC_ID="HGNC:3800" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="1609915" stop="1613897" display_start="1609915" display_stop="1613897" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="1610680" stop="1614131" display_start="1610680" display_stop="1614131" Strand="+" />
          </Location>
          <OMIM>601090</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001453.3(FOXC1):c.474dup (p.Tyr159fs)</Name>
      <CanonicalSPDI>NC_000006.12:1610917:CC:CCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="1610917" stop="1610918" display_start="1610917" display_stop="1610918" variantLength="1" positionVCF="1610917" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="1611152" stop="1611153" display_start="1611152" display_stop="1611153" variantLength="1" positionVCF="1611152" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>Y159fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.1611154dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.1611154dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.1610919dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.1610919dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009368.1" sequenceAccession="NG_009368" sequenceVersion="1" change="g.5474dup">
            <Expression>NG_009368.1:g.5474dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001453.3" sequenceAccession="NM_001453" sequenceVersion="3" change="c.474dup" MANESelect="true">
            <Expression>NM_001453.3:c.474dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001444.2" sequenceAccession="NP_001444" sequenceVersion="2" change="p.Tyr159fs">
            <Expression>NP_001444.2:p.Tyr159fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1245" sequenceAccession="LRG_1245">
            <Expression>LRG_1245:g.5474dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1245t1" sequenceAccession="LRG_1245t1">
            <Expression>LRG_1245t1:c.474dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1245p1" sequenceAccession="LRG_1245p1" change="p.Tyr159fs">
            <Expression>LRG_1245p1:p.Tyr159fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001453.3(FOXC1):c.474dup (p.Tyr159fs) AND Axenfeld-Rieger syndrome type 3" Accession="RCV002816555" Version="2">
        <ClassifiedConditionList TraitSetID="2331">
          <ClassifiedCondition DB="MedGen" ID="C2678503">Axenfeld-Rieger syndrome type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32499604</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2331" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="371" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Axenfeld-Rieger syndrome type 3</ElementValue>
                <XRef ID="Axenfeld+Rieger+Syndrome+Type+3/694" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011233" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Axenfeld-rieger anomaly with or without cardiac defects and/or sensorineural hearing loss</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rieger syndrome type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anterior chamber cleavage syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AXENFELD-RIEGER ANOMALY WITH CARDIAC DEFECTS AND/OR SENSORINEURAL HEARING LOSS</ElementValue>
                <XRef Type="MIM" ID="602482" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RIEG3</ElementValue>
                <XRef Type="MIM" ID="602482" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9626" />
                <XRef ID="9626" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="pmc">3061995</ID>
              </Citation>
              <XRef ID="782" DB="Orphanet" />
              <XRef ID="C2678503" DB="MedGen" />
              <XRef ID="MONDO:0011233" DB="MONDO" />
              <XRef Type="MIM" ID="602482" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5906377" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16919270|MedGen:C2678503" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003216858" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32499604</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FOXC1 protein in which other variant(s) (p.Gln467*) have been determined to be pathogenic (PMID: 32499604; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with FOXC1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr159Leufs*147) in the FOXC1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 395 amino acid(s) of the FOXC1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.1611152_1611153insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2678503" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5906377" TraitType="Disease" MappingType="XRef" MappingValue="C2678503" MappingRef="MedGen">
        <MedGen CUI="C2678503" Name="Axenfeld-Rieger syndrome type 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

